We were delighted to be named 2017 Start Up Start-Up of the Year by BioNow, the northern England bio-medical and life sciences membership organisation.

It’s been an outstanding year for ApconiX with more than 60 clients across the UK, US and Europe including Pfizer, UCB and Gilead, as well as bio-techs, start-ups and university spin-outs. Current clients also include the US Food and Drug Administration (FDA) and the Institute for Cancer Research.

As well as this unprecedented expansion of our client base, we also achieved a five-fold sales increase in our second year of trading, far exceeding our predicted annual forecast.

Many thanks to BioNow for selecting us for this great honour and to RSM for sponsoring the award!